User profiles for Harold Lau

Harold Lau

University of Calgary
Verified email at ucalgary.ca
Cited by 3822

Management of cancer cachexia: ASCO guideline

…, S Dixon, M Fallon, J Herrstedt, H Lau… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide evidence-based guidance on the clinical management of cancer
cachexia in adult patients with advanced cancer. METHODS A systematic review of the literature …

Management of salivary gland malignancy: ASCO guideline

…, M Kaufman, E Lamarre, HY Lau… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE To provide evidence-based recommendations for practicing physicians and other
healthcare providers on the management of salivary gland malignancy. METHODS ASCO …

Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial

…, W Bosch, DW Bruner, JP Bahary, H Lau… - JAMA …, 2018 - jamanetwork.com
Importance Optimizing radiation therapy techniques for localized prostate cancer can affect
patient outcomes. Dose escalation improves biochemical control, but no prior trials were …

Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention

SN Culos-Reed, JW Robinson, H Lau… - Supportive Care in …, 2010 - Springer
Goals of work Prostate cancer patients receiving androgen deprivation therapy (ADT) are
vulnerable to a number of potentially debilitating side effects, which can significantly impact …

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer

…, SD Ernst, JC Rewcastle, H Lau… - … Journal of the …, 2010 - Wiley Online Library
BACKGROUND: Localized prostate cancer can be treated several different ways, but head‐to‐head
comparisons of treatments are infrequent. The authors of this report conducted a …

Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma

…, D Dayan, JC Dort, K Heller, G Jour, H Lau… - Head and neck …, 2013 - Springer
The Risk Model is a validated outcome predictor for patients with head and neck squamous
cell carcinoma (Brandwein-Gensler et al. in Am J Surg Pathol 20:167–178, 2005 ; Am J Surg …

Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial

L Rudmik, HY Lau, TW Matthews, JD Bosch… - Head & …, 2011 - Wiley Online Library
Background Metastatic head and neck squamous cell carcinoma with an unknown primary
is an uncommon but important problem. PET/CT, as an adjunct to diagnosis, is potentially …

Patient‐reported outcomes, body composition, and nutrition status in patients with head and neck cancer: results from an exploratory randomized controlled exercise …

LC Capozzi, ML McNeely, HY Lau, RA Reimer… - Cancer, 2016 - Wiley Online Library
BACKGROUND Patients with head and neck cancer experience loss of weight and muscle
mass, decreased functioning, malnutrition, depression, and declines in quality of life during …

The impact of physical activity on health-related fitness and quality of life for patients with head and neck cancer: a systematic review

…, KC Nishimura, ML McNeely, H Lau… - British journal of sports …, 2016 - bjsm.bmj.com
Background Patients with head and neck cancer often face a plethora of cancer and
treatment-related side effects, negatively impacting their lean body mass, physical functioning, …

Benefits of a physical activity intervention for men with prostate cancer

…, JL Robinson, H Lau… - Journal of sport …, 2007 - journals.humankinetics.com
The purpose of the current study was to examine the viability of conducting a theory-based
physical activity (PA) intervention on men with prostate cancer, and the impact of PA on …